Diabetes

  • Evaluation and management of orthostatic hypotension: Limited data, limitless opportunity
    Aldo J. Peixoto, MD
    Cleveland Clinic Journal of Medicine January 2022, 89 (1) 36-45; DOI: https://doi.org/10.3949/ccjm.89gr.22001

    Orthostatic hypotension is common and can have serious consequences. The author offers a systematic approach to evaluation and management.

  • Ketogenic diets in the management of type 1 diabetes: Safe or safety concern?
    Lauren Anne Buehler, MD, MPH, Dawn Noe, RDN, LD, CDCES, Shannon Knapp, BSN, RN, CDCES, Diana Isaacs, Pharm D, CDCES and Kevin M. Pantalone, DO, ECNU, FACE
    Cleveland Clinic Journal of Medicine October 2021, 88 (10) 547-555; DOI: https://doi.org/10.3949/ccjm.88a.20121

    A review of the potential risks and benefits for managing type 1 diabetes based on available evidence.

  • Leriche syndrome
    Hiroki Matsuura, MD and Hiroyuki Honda, MD, PhD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 482-483; DOI: https://doi.org/10.3949/ccjm.88a.20179

    Physical examination revealed pallor of the toes, cold extremities, dry skin, and absence of bilateral femoral pulses. The patient also disclosed erectile dysfunction.

  • How do you effectively evaluate the elderly for alcohol use disorder?
    Moronkeji Fagbemi, MD, FASAM
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 434-439; DOI: https://doi.org/10.3949/ccjm.88a.20123

    A brief review of clues to an underrecognized and underdiagnosed problem with physical as well as emotional and social consequences.

  • The obesity paradox in heart failure: What is the role of cardiorespiratory fitness?
    Asad Khan, MD, Erik H. Van Iterson, PhD and Luke J. Laffin, MD
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 449-458; DOI: https://doi.org/10.3949/ccjm.88a.20098

    What should these patients be advised about weight management and about cardiorespiratory fitness, a major factor influencing the paradox?

  • Medical complications of bulimia nervosa
    Allison Nitsch, MD, Heather Dlugosz, MD, Dennis Gibson, MD and Philip S. Mehler, MD, FACP, FAED
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 333-343; DOI: https://doi.org/10.3949/ccjm.88a.20168

    Complications can affect all body systems, but especially the renal and electrolyte systems.

  • How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
    Wendy O. Henderson, MD, Mary H. Parker, PharmD, FASHP, FCCP, BCPS, BCCP and Bryan C. Batch, MD, MHS
    Cleveland Clinic Journal of Medicine February 2021, 88 (2) 81-85; DOI: https://doi.org/10.3949/ccjm.88a.19135

    Hemoglobin A1c is the standard but is not perfect. Alternatives are available.

  • The role of SGLT-2 inhibitors in managing type 2 diabetes
    Yumiko Tsushima, MD, M. Cecilia Lansang, MD, MPH and Vinni Makin, MBBS, MD, FACE
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 47-58; DOI: https://doi.org/10.3949/ccjm.88a.20088

    These drugs improve glycemic control and offer cardiovascular and metabolic benefits.

  • SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
    Jonathan J. Taliercio, DO, George Thomas, MD, Georges N. Nakhoul, MD, MEd, Tushar J. Vachharajani, MD and Ali Mehdi, MD, MEd
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 59-63; DOI: https://doi.org/10.3949/ccjm.88a.20190

    Randomized controlled trials of these new agents had positive outcomes.

  • Peripheral artery disease and unusual skin findings
    Aaron Andrew Heigaard Smith, MD, Erin Luxenberg, MD and Roberta Meyers, MD, MPH
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 605-612; DOI: https://doi.org/10.3949/ccjm.87a.19074

    A 68-year-old man was admitted because of worsening skin problems in his legs.

Pages